AAAAAA

   
Results: 1-25 | 26-35 |
Results: 26-35/35
Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens
Authors: Castelli, C Tarsini, P Mazzocchi, A Rini, F Rivoltini, L Ravagnani, F Gallino, F Belli, F Parmiani, G
Citation: C. Castelli et al., Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens, J IMMUNOL, 162(3), 1999, pp. 1739-1748
An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions
Authors: Anichini, A Molla, A Mortarini, R Tragni, G Bersani, I Di Nicola, M Gianni, AM Pilotti, S Dunbar, R Cerundolo, V Parmiani, G
Citation: A. Anichini et al., An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions, J EXP MED, 190(5), 1999, pp. 651-667
Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells
Authors: Wang, ZG Marincola, FM Rivoltini, L Parmiani, G Ferrone, S
Citation: Zg. Wang et al., Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells, J EXP MED, 190(2), 1999, pp. 205-215
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
Authors: Marchand, M van Baren, N Weynants, P Brichard, V Dreno, B Tessier, MH Rankin, E Parmiani, G Arienti, F Humblet, Y Bourlond, A Vanwijck, R Lienard, D Beauduin, M Dietrich, PY Russo, V Kerger, J Masucci, G Jager, E De Greve, J Atzpodien, J Brasseur, F Coulie, PG Van der Bruggen, P Boon, T
Citation: M. Marchand et al., Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1, INT J CANC, 80(2), 1999, pp. 219-230
A superagonist variant of peptide MART1/melan A(27-35) elicits anti-melanoma CD8(+) T cells with enhanced functional characteristics: Implication formore effective immunotherapy
Authors: Rivoltini, L Squarcina, P Loftus, DJ Castelli, C Tarsini, P Mazzocchi, A Rini, F Viggiano, V Belli, F Parmiani, G
Citation: L. Rivoltini et al., A superagonist variant of peptide MART1/melan A(27-35) elicits anti-melanoma CD8(+) T cells with enhanced functional characteristics: Implication formore effective immunotherapy, CANCER RES, 59(2), 1999, pp. 301-306
Melanoma: The Milan melanoma cell lines
Authors: Anichini, A Mortarini, R Vegetti, C Molla, A Borri, A Parmiani, G
Citation: A. Anichini et al., Melanoma: The Milan melanoma cell lines, HUM CEL CUL, 1, 1999, pp. 283-292
Human dendritic cells: natural adjuvants in antitumor immunotherapy
Authors: Di Nicola, M Anichini, A Mortarini, R Bregni, M Parmiani, G Gianni, AM
Citation: M. Di Nicola et al., Human dendritic cells: natural adjuvants in antitumor immunotherapy, CYTOK CELL, 4(4), 1998, pp. 265-273
Identification of antigens recognized by T lymphocytes on human tumours, and pilot vaccination studies with defined antigens
Authors: Boon, T Parmiani, G Cerottini, JC Coulie, P Melief, CJM Wolfel, T Rammensee, HG
Citation: T. Boon et al., Identification of antigens recognized by T lymphocytes on human tumours, and pilot vaccination studies with defined antigens, BIOM HLTH R, 24, 1998, pp. 3-12
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors
Authors: Di Nicola, M Siena, S Bregni, M Longoni, P Magni, M Milanesi, M Matteucci, P Mortarini, R Anichini, A Parmiani, G Drexler, I Erfle, V Sutter, G Gianni, AM
Citation: M. Di Nicola et al., Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors, CANC GENE T, 5(6), 1998, pp. 350-356
Gene modified human melanoma cell vaccines: new strategies
Authors: Parmiani, G
Citation: G. Parmiani, Gene modified human melanoma cell vaccines: new strategies, EUROCANCER 98, 1998, pp. 299-299
Risultati: 1-25 | 26-35 |